PDB Short entry for 2VR3 HEADER CELL ADHESION 25-MAR-08 2VR3 TITLE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO TITLE 2 CLFA FROM STAPHYLOCCCUS AUREUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLUMPING FACTOR A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N2N3, RESIDUES 229-545; COMPND 5 SYNONYM: FIBRINOGEN-BINDING PROTEIN A, FIBRINOGEN RECEPTOR A; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: ENGINEERED DISULFIDE BOND BETWEEN 327 AND 541; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: FIBRINOGEN GAMMA-CHAIN; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: C-TERMINAL GAMMA-CHAIN PEPTIDE ANALOG, RESIDUES 425-437; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS PLATELET AGGREGATION, PEPTIDOGLYCAN-ANCHOR, CELL ADHESION, KEYWDS 2 STAPHYLOCOCCUS AUREUS, FIBRINOGEN GAMMA-CHAIN, SECRETED, CELL WALL, KEYWDS 3 VIRULENCE, CLUMPING FACTOR EXPDTA X-RAY DIFFRACTION AUTHOR V.K.GANESH,J.J.RIVERA,E.SMEDS,M.G.BOWDEN,E.R.WANN,S.GURUSIDAPPA, AUTHOR 2 J.R.FITZGERALD,M.HOOK REVDAT 2 13-DEC-23 2VR3 1 REMARK REVDAT 1 19-MAY-09 2VR3 0 JRNL AUTH V.K.GANESH,J.J.RIVERA,E.SMEDS,Y.P.KO,M.G.BOWDEN,E.R.WANN, JRNL AUTH 2 S.GURUSIDDAPPA,J.R.FITZGERALD,M.HOOK JRNL TITL A STRUCTURAL MODEL OF THE STAPHYLOCOCCUS AUREUS JRNL TITL 2 CLFA-FIBRINOGEN INTERACTION OPENS NEW AVENUES FOR THE DESIGN JRNL TITL 3 OF ANTI-STAPHYLOCOCCAL THERAPEUTICS. JRNL REF PLOS PATHOG. V. 4 226 2008 JRNL REFN ISSN 1553-7366 JRNL PMID 19043557 JRNL DOI 10.1371/JOURNAL.PPAT.1000226 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 45132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 941 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3145 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4699 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 527 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.40000 REMARK 3 B22 (A**2) : 0.82000 REMARK 3 B33 (A**2) : -2.26000 REMARK 3 B12 (A**2) : 0.63000 REMARK 3 B13 (A**2) : -0.27000 REMARK 3 B23 (A**2) : -0.30000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.179 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.191 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.092 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.108 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4787 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6558 ; 1.642 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 634 ; 7.367 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;41.094 ;26.421 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 673 ;15.073 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;12.466 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 783 ; 0.116 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3656 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2251 ; 0.259 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3303 ; 0.332 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 719 ; 0.300 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.322 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.181 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VR3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1290035780. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49456 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.75 REMARK 200 R MERGE FOR SHELL (I) : 0.19800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1N67 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20% PEG 8000, 100MM SUCCINIC ACID REMARK 280 PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 327 TO CYS REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 541 TO CYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASP 327 TO CYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LYS 541 TO CYS REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ASP 436 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN D, ASP 436 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 217 REMARK 465 ARG A 218 REMARK 465 GLY A 219 REMARK 465 SER A 220 REMARK 465 HIS A 221 REMARK 465 HIS A 222 REMARK 465 HIS A 223 REMARK 465 HIS A 224 REMARK 465 HIS A 225 REMARK 465 HIS A 226 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 GLY A 229 REMARK 465 GLY A 300 REMARK 465 ASP A 301 REMARK 465 GLN A 302 REMARK 465 GLU A 453 REMARK 465 ASN A 454 REMARK 465 PHE A 455 REMARK 465 ASN A 477 REMARK 465 THR A 478 REMARK 465 MET B 217 REMARK 465 ARG B 218 REMARK 465 GLY B 219 REMARK 465 SER B 220 REMARK 465 HIS B 221 REMARK 465 HIS B 222 REMARK 465 HIS B 223 REMARK 465 HIS B 224 REMARK 465 HIS B 225 REMARK 465 HIS B 226 REMARK 465 GLY B 227 REMARK 465 SER B 228 REMARK 465 GLY B 229 REMARK 465 ASP B 439 REMARK 465 ASN B 477 REMARK 465 THR B 478 REMARK 465 VAL B 544 REMARK 465 PRO B 545 REMARK 465 GLN C 399 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 230 OG1 CG2 REMARK 470 THR A 247 OG1 CG2 REMARK 470 LYS A 258 CE NZ REMARK 470 VAL A 270 CG1 CG2 REMARK 470 LYS A 271 CG CD CE NZ REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 LYS A 293 CG CD CE NZ REMARK 470 ASP A 321 CG OD1 OD2 REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 ASN A 343 ND2 REMARK 470 LYS A 346 NZ REMARK 470 LYS A 371 CD CE NZ REMARK 470 GLN A 428 OE1 NE2 REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 LYS A 434 CD CE NZ REMARK 470 ASP A 439 CG OD1 OD2 REMARK 470 ASN A 440 CG OD1 ND2 REMARK 470 ASN A 451 CG OD1 ND2 REMARK 470 GLU A 456 CG CD OE1 OE2 REMARK 470 VAL A 462 CG1 CG2 REMARK 470 GLU A 475 CD OE1 OE2 REMARK 470 ASP A 480 CG OD1 OD2 REMARK 470 GLN A 482 CG CD OE1 NE2 REMARK 470 LYS A 500 CG CD CE NZ REMARK 470 ILE A 516 CG1 CG2 CD1 REMARK 470 ASP A 537 CG OD1 OD2 REMARK 470 ILE A 539 CG1 CG2 CD1 REMARK 470 VAL A 543 CG1 CG2 REMARK 470 VAL A 544 CG1 CG2 REMARK 470 PRO A 545 CG CD REMARK 470 LYS B 258 NZ REMARK 470 ASP B 301 CG OD1 OD2 REMARK 470 GLN B 302 CG CD OE1 NE2 REMARK 470 VAL B 303 CG1 CG2 REMARK 470 LYS B 330 CE NZ REMARK 470 LYS B 346 CE NZ REMARK 470 LYS B 371 CD CE NZ REMARK 470 TYR B 376 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR B 390 CG2 REMARK 470 ARG B 395 NE CZ NH1 NH2 REMARK 470 ILE B 408 CD1 REMARK 470 ASN B 419 CG OD1 ND2 REMARK 470 ASP B 421 CG OD1 OD2 REMARK 470 GLN B 428 CG CD OE1 NE2 REMARK 470 GLN B 429 CG CD OE1 NE2 REMARK 470 LYS B 434 CE NZ REMARK 470 LYS B 437 CE NZ REMARK 470 VAL B 438 CG1 CG2 REMARK 470 ASN B 440 CB CG OD1 ND2 REMARK 470 ALA B 441 CB REMARK 470 VAL B 450 CG1 CG2 REMARK 470 GLU B 453 CG CD OE1 OE2 REMARK 470 ASN B 460 CG OD1 ND2 REMARK 470 VAL B 462 CG1 CG2 REMARK 470 LYS B 473 NZ REMARK 470 PRO B 479 CG CD REMARK 470 ASP B 480 CB CG OD1 OD2 REMARK 470 GLN B 482 CG CD OE1 NE2 REMARK 470 LYS B 500 CG CD CE NZ REMARK 470 ILE B 516 CD1 REMARK 470 ASP B 537 CG OD1 OD2 REMARK 470 ILE B 539 CD1 REMARK 470 VAL B 543 CA C O CB CG1 CG2 REMARK 470 HIS C 400 CB CG ND1 CD2 CE1 NE2 REMARK 470 HIS C 401 CG ND1 CD2 CE1 NE2 REMARK 470 GLN D 399 CB CG CD OE1 NE2 REMARK 470 HIS D 400 CB CG ND1 CD2 CE1 NE2 REMARK 470 HIS D 401 ND1 CD2 CE1 NE2 REMARK 470 LYS D 406 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 432 O HOH B 2195 1.82 REMARK 500 O SER A 290 O HOH A 2050 1.83 REMARK 500 O HOH B 2155 O HOH B 2172 1.90 REMARK 500 NZ LYS A 276 O HOH A 2035 1.93 REMARK 500 O LYS A 276 O HOH A 2036 1.98 REMARK 500 OH TYR A 372 O HOH A 2128 2.00 REMARK 500 NZ LYS B 281 O HOH B 2045 2.01 REMARK 500 OD2 ASP B 231 O HOH B 2002 2.04 REMARK 500 O HOH B 2231 O HOH B 2235 2.06 REMARK 500 O HOH A 2040 O HOH A 2041 2.07 REMARK 500 O HOH A 2002 O HOH A 2077 2.08 REMARK 500 OG1 THR A 351 OG1 THR A 364 2.08 REMARK 500 NZ LYS B 281 O HOH B 2044 2.08 REMARK 500 O HOH B 2059 O HOH B 2062 2.10 REMARK 500 O HOH B 2071 O HOH B 2073 2.12 REMARK 500 O HOH B 2049 O HOH B 2102 2.13 REMARK 500 OG SER A 432 O HOH A 2180 2.14 REMARK 500 O HOH B 2059 O HOH B 2072 2.15 REMARK 500 N VAL A 303 O HOH A 2061 2.15 REMARK 500 O HOH A 2222 O HOH A 2228 2.15 REMARK 500 O HOH B 2013 O HOH B 2085 2.16 REMARK 500 O HOH B 2172 O HOH B 2173 2.16 REMARK 500 ND2 ASN A 525 O HOH A 2239 2.16 REMARK 500 O HOH A 2059 O HOH A 2060 2.17 REMARK 500 O HOH A 2179 O HOH A 2181 2.18 REMARK 500 O HOH B 2190 O HOH B 2254 2.18 REMARK 500 O HOH A 2149 O HOH A 2170 2.18 REMARK 500 O THR B 420 O HOH B 2184 2.18 REMARK 500 O HOH A 2132 O HOH A 2134 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 341 C - N - CA ANGL. DEV. = 12.7 DEGREES REMARK 500 PRO A 545 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 PRO B 410 C - N - CA ANGL. DEV. = 10.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 370 -152.94 63.77 REMARK 500 TYR A 376 -124.83 44.03 REMARK 500 ILE A 380 139.34 -173.09 REMARK 500 TYR A 448 5.34 82.94 REMARK 500 PHE A 466 77.09 -118.34 REMARK 500 GLU B 370 -149.99 64.51 REMARK 500 TYR B 376 -123.33 52.01 REMARK 500 GLN B 386 133.89 -176.96 REMARK 500 ASN B 419 14.81 53.75 REMARK 500 ASN B 513 -158.12 -96.31 REMARK 500 ASP B 537 -158.81 -150.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2113 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH A2143 DISTANCE = 6.03 ANGSTROMS REMARK 525 HOH B2136 DISTANCE = 6.23 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D REMARK 900 RELATED ID: 1RF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGENWITH THE REMARK 900 PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE REMARK 900 RELATED ID: 1LT9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D REMARK 900 RELATED ID: 1FID RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT REMARK 900 RELATED ID: 1FZC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO REMARK 900 DIFFERENT BOUND LIGANDS REMARK 900 RELATED ID: 1N8E RELATED DB: PDB REMARK 900 FRAGMENT DOUBLE-D FROM HUMAN FIBRIN REMARK 900 RELATED ID: 1RE4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN REMARK 900 RELATED ID: 1N86 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN D-DIMER FROM CROSS-LINKED REMARK 900 FIBRINCOMPLEXED WITH GPR AND GHRPLDK PEPTIDE LIGANDS. REMARK 900 RELATED ID: 1FZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D REMARK 900 RELATED ID: 1DUG RELATED DB: PDB REMARK 900 STRUCTURE OF THE FIBRINOGEN G CHAIN INTEGRIN BINDING ANDFACTOR REMARK 900 XIIIA CROSSLINKING SITES OBTAINED THROUGH CARRIERPROTEIN DRIVEN REMARK 900 CRYSTALLIZATION REMARK 900 RELATED ID: 1RE3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGENWITH THE REMARK 900 PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE REMARK 900 RELATED ID: 1LTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENTD WITH REMARK 900 THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG -PRO-AMIDE REMARK 900 RELATED ID: 1FZG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE REMARK 900 PEPTIDE LIGAND GLY-HIS- ARG-PRO-AMIDE REMARK 900 RELATED ID: 1FZF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE REMARK 900 PEPTIDE LIGAND GLY- HIS-ARG-PRO-AMIDE REMARK 900 RELATED ID: 2FIB RELATED DB: PDB REMARK 900 RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT REMARK 900 (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY-PRO-ARG-PRO AT PH REMARK 900 6.0 REMARK 900 RELATED ID: 2FFD RELATED DB: PDB REMARK 900 FIBRINOGEN FRAGMENT D WITH "A" KNOB PEPTIDE MIMIC GPRVVE REMARK 900 RELATED ID: 1FZE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN REMARK 900 RELATED ID: 1RF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN REMARK 900 RELATED ID: 1FIC RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT REMARK 900 RELATED ID: 1FIB RELATED DB: PDB REMARK 900 RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT REMARK 900 (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0 REMARK 900 RELATED ID: 3FIB RELATED DB: PDB REMARK 900 RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT REMARK 900 (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0: A FURTHER REFINEMENT REMARK 900 OF PDB ENTRY 1FIB, AND DIFFERS FROM 1FIB BY THE MODELLING OF A CIS REMARK 900 PEPTIDE BOND BETWEEN RESIDUES K338 AND C339 DBREF 2VR3 A 217 228 PDB 2VR3 2VR3 217 228 DBREF 2VR3 A 229 545 UNP Q2G015 CLFA_STAA8 229 545 DBREF 2VR3 B 217 228 PDB 2VR3 2VR3 217 228 DBREF 2VR3 B 229 545 UNP Q2G015 CLFA_STAA8 229 545 DBREF 2VR3 C 399 411 UNP P02679 FIBG_HUMAN 425 437 DBREF 2VR3 D 399 411 UNP P02679 FIBG_HUMAN 425 437 SEQADV 2VR3 CYS A 327 UNP Q2G015 ASP 327 ENGINEERED MUTATION SEQADV 2VR3 CYS A 541 UNP Q2G015 LYS 541 ENGINEERED MUTATION SEQADV 2VR3 CYS B 327 UNP Q2G015 ASP 327 ENGINEERED MUTATION SEQADV 2VR3 CYS B 541 UNP Q2G015 LYS 541 ENGINEERED MUTATION SEQADV 2VR3 ALA C 410 UNP P02679 ASP 436 ENGINEERED MUTATION SEQADV 2VR3 ALA D 410 UNP P02679 ASP 436 ENGINEERED MUTATION SEQRES 1 A 329 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 A 329 THR ASP ILE THR ASN GLN LEU THR ASN VAL THR VAL GLY SEQRES 3 A 329 ILE ASP SER GLY THR THR VAL TYR PRO HIS GLN ALA GLY SEQRES 4 A 329 TYR VAL LYS LEU ASN TYR GLY PHE SER VAL PRO ASN SER SEQRES 5 A 329 ALA VAL LYS GLY ASP THR PHE LYS ILE THR VAL PRO LYS SEQRES 6 A 329 GLU LEU ASN LEU ASN GLY VAL THR SER THR ALA LYS VAL SEQRES 7 A 329 PRO PRO ILE MET ALA GLY ASP GLN VAL LEU ALA ASN GLY SEQRES 8 A 329 VAL ILE ASP SER ASP GLY ASN VAL ILE TYR THR PHE THR SEQRES 9 A 329 ASP TYR VAL ASN THR LYS CYS ASP VAL LYS ALA THR LEU SEQRES 10 A 329 THR MET PRO ALA TYR ILE ASP PRO GLU ASN VAL LYS LYS SEQRES 11 A 329 THR GLY ASN VAL THR LEU ALA THR GLY ILE GLY SER THR SEQRES 12 A 329 THR ALA ASN LYS THR VAL LEU VAL ASP TYR GLU LYS TYR SEQRES 13 A 329 GLY LYS PHE TYR ASN LEU SER ILE LYS GLY THR ILE ASP SEQRES 14 A 329 GLN ILE ASP LYS THR ASN ASN THR TYR ARG GLN THR ILE SEQRES 15 A 329 TYR VAL ASN PRO SER GLY ASP ASN VAL ILE ALA PRO VAL SEQRES 16 A 329 LEU THR GLY ASN LEU LYS PRO ASN THR ASP SER ASN ALA SEQRES 17 A 329 LEU ILE ASP GLN GLN ASN THR SER ILE LYS VAL TYR LYS SEQRES 18 A 329 VAL ASP ASN ALA ALA ASP LEU SER GLU SER TYR PHE VAL SEQRES 19 A 329 ASN PRO GLU ASN PHE GLU ASP VAL THR ASN SER VAL ASN SEQRES 20 A 329 ILE THR PHE PRO ASN PRO ASN GLN TYR LYS VAL GLU PHE SEQRES 21 A 329 ASN THR PRO ASP ASP GLN ILE THR THR PRO TYR ILE VAL SEQRES 22 A 329 VAL VAL ASN GLY HIS ILE ASP PRO ASN SER LYS GLY ASP SEQRES 23 A 329 LEU ALA LEU ARG SER THR LEU TYR GLY TYR ASN SER ASN SEQRES 24 A 329 ILE ILE TRP ARG SER MET SER TRP ASP ASN GLU VAL ALA SEQRES 25 A 329 PHE ASN ASN GLY SER GLY SER GLY ASP GLY ILE ASP CYS SEQRES 26 A 329 PRO VAL VAL PRO SEQRES 1 B 329 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 B 329 THR ASP ILE THR ASN GLN LEU THR ASN VAL THR VAL GLY SEQRES 3 B 329 ILE ASP SER GLY THR THR VAL TYR PRO HIS GLN ALA GLY SEQRES 4 B 329 TYR VAL LYS LEU ASN TYR GLY PHE SER VAL PRO ASN SER SEQRES 5 B 329 ALA VAL LYS GLY ASP THR PHE LYS ILE THR VAL PRO LYS SEQRES 6 B 329 GLU LEU ASN LEU ASN GLY VAL THR SER THR ALA LYS VAL SEQRES 7 B 329 PRO PRO ILE MET ALA GLY ASP GLN VAL LEU ALA ASN GLY SEQRES 8 B 329 VAL ILE ASP SER ASP GLY ASN VAL ILE TYR THR PHE THR SEQRES 9 B 329 ASP TYR VAL ASN THR LYS CYS ASP VAL LYS ALA THR LEU SEQRES 10 B 329 THR MET PRO ALA TYR ILE ASP PRO GLU ASN VAL LYS LYS SEQRES 11 B 329 THR GLY ASN VAL THR LEU ALA THR GLY ILE GLY SER THR SEQRES 12 B 329 THR ALA ASN LYS THR VAL LEU VAL ASP TYR GLU LYS TYR SEQRES 13 B 329 GLY LYS PHE TYR ASN LEU SER ILE LYS GLY THR ILE ASP SEQRES 14 B 329 GLN ILE ASP LYS THR ASN ASN THR TYR ARG GLN THR ILE SEQRES 15 B 329 TYR VAL ASN PRO SER GLY ASP ASN VAL ILE ALA PRO VAL SEQRES 16 B 329 LEU THR GLY ASN LEU LYS PRO ASN THR ASP SER ASN ALA SEQRES 17 B 329 LEU ILE ASP GLN GLN ASN THR SER ILE LYS VAL TYR LYS SEQRES 18 B 329 VAL ASP ASN ALA ALA ASP LEU SER GLU SER TYR PHE VAL SEQRES 19 B 329 ASN PRO GLU ASN PHE GLU ASP VAL THR ASN SER VAL ASN SEQRES 20 B 329 ILE THR PHE PRO ASN PRO ASN GLN TYR LYS VAL GLU PHE SEQRES 21 B 329 ASN THR PRO ASP ASP GLN ILE THR THR PRO TYR ILE VAL SEQRES 22 B 329 VAL VAL ASN GLY HIS ILE ASP PRO ASN SER LYS GLY ASP SEQRES 23 B 329 LEU ALA LEU ARG SER THR LEU TYR GLY TYR ASN SER ASN SEQRES 24 B 329 ILE ILE TRP ARG SER MET SER TRP ASP ASN GLU VAL ALA SEQRES 25 B 329 PHE ASN ASN GLY SER GLY SER GLY ASP GLY ILE ASP CYS SEQRES 26 B 329 PRO VAL VAL PRO SEQRES 1 C 13 GLN HIS HIS LEU GLY GLY ALA LYS GLN ALA GLY ALA VAL SEQRES 1 D 13 GLN HIS HIS LEU GLY GLY ALA LYS GLN ALA GLY ALA VAL FORMUL 5 HOH *527(H2 O) HELIX 1 1 ILE A 232 LEU A 236 5 5 HELIX 2 2 ASP A 321 THR A 325 1 5 HELIX 3 3 ASN A 440 LEU A 444 5 5 HELIX 4 4 VAL A 458 VAL A 462 5 5 HELIX 5 5 ILE B 232 LEU B 236 5 5 HELIX 6 6 TYR B 250 HIS B 252 5 3 HELIX 7 7 ASP B 321 ASN B 324 5 4 HELIX 8 8 ASN B 440 LEU B 444 5 5 HELIX 9 9 ASN B 451 PHE B 455 5 5 HELIX 10 10 THR B 459 VAL B 462 5 4 SHEET 1 AA 4 THR A 237 ASP A 244 0 SHEET 2 AA 4 VAL A 257 VAL A 265 -1 O LYS A 258 N ASP A 244 SHEET 3 AA 4 LYS A 326 ILE A 339 -1 O VAL A 329 N VAL A 265 SHEET 4 AA 4 LEU A 283 ASN A 284 -1 O ASN A 284 N TYR A 338 SHEET 1 AB 5 THR A 237 ASP A 244 0 SHEET 2 AB 5 VAL A 257 VAL A 265 -1 O LYS A 258 N ASP A 244 SHEET 3 AB 5 LYS A 326 ILE A 339 -1 O VAL A 329 N VAL A 265 SHEET 4 AB 5 SER A 533 ASP A 540 -1 O SER A 533 N THR A 334 SHEET 5 AB 5 ILE A 297 MET A 298 1 O MET A 298 N GLY A 536 SHEET 1 AC 6 THR A 248 VAL A 249 0 SHEET 2 AC 6 THR A 359 VAL A 367 1 O LEU A 366 N VAL A 249 SHEET 3 AC 6 GLY A 348 ILE A 356 -1 O GLY A 348 N VAL A 367 SHEET 4 AC 6 THR A 274 THR A 278 -1 O THR A 278 N GLY A 355 SHEET 5 AC 6 VAL A 315 PHE A 319 -1 O VAL A 315 N ILE A 277 SHEET 6 AC 6 ALA A 305 ILE A 309 -1 O ASN A 306 N THR A 318 SHEET 1 AD 5 GLY A 373 PHE A 375 0 SHEET 2 AD 5 LEU A 378 ASP A 388 -1 O LEU A 378 N PHE A 375 SHEET 3 AD 5 THR A 393 VAL A 400 -1 O THR A 393 N ASP A 388 SHEET 4 AD 5 TYR A 487 ILE A 495 -1 O TYR A 487 N VAL A 400 SHEET 5 AD 5 ALA A 424 LEU A 425 -1 O LEU A 425 N HIS A 494 SHEET 1 AE 5 GLY A 373 PHE A 375 0 SHEET 2 AE 5 LEU A 378 ASP A 388 -1 O LEU A 378 N PHE A 375 SHEET 3 AE 5 THR A 393 VAL A 400 -1 O THR A 393 N ASP A 388 SHEET 4 AE 5 TYR A 487 ILE A 495 -1 O TYR A 487 N VAL A 400 SHEET 5 AE 5 SER A 432 LYS A 437 -1 O SER A 432 N ASN A 492 SHEET 1 AF 4 ASN A 463 ASN A 468 0 SHEET 2 AF 4 GLN A 471 GLU A 475 -1 O GLN A 471 N ASN A 468 SHEET 3 AF 4 VAL A 407 LEU A 416 -1 O LEU A 412 N VAL A 474 SHEET 4 AF 4 GLN A 482 ILE A 483 -1 O ILE A 483 N VAL A 407 SHEET 1 AG 6 ASN A 463 ASN A 468 0 SHEET 2 AG 6 GLN A 471 GLU A 475 -1 O GLN A 471 N ASN A 468 SHEET 3 AG 6 VAL A 407 LEU A 416 -1 O LEU A 412 N VAL A 474 SHEET 4 AG 6 LEU A 505 TYR A 512 -1 O ARG A 506 N ASN A 415 SHEET 5 AG 6 TRP A 518 ASN A 530 -1 O ARG A 519 N GLY A 511 SHEET 6 AG 6 HIS C 401 ALA C 410 1 O HIS C 401 N SER A 522 SHEET 1 BA14 THR B 237 ASP B 244 0 SHEET 2 BA14 VAL B 257 VAL B 265 -1 O LYS B 258 N ASP B 244 SHEET 3 BA14 LYS B 326 ILE B 339 -1 O VAL B 329 N VAL B 265 SHEET 4 BA14 THR B 248 VAL B 249 0 SHEET 5 BA14 THR B 359 VAL B 367 1 O LEU B 366 N VAL B 249 SHEET 6 BA14 GLY B 348 ILE B 356 -1 O GLY B 348 N VAL B 367 SHEET 7 BA14 THR B 274 THR B 278 -1 O THR B 278 N GLY B 355 SHEET 8 BA14 VAL B 315 PHE B 319 -1 O VAL B 315 N ILE B 277 SHEET 9 BA14 GLN B 302 ILE B 309 -1 O ASN B 306 N THR B 318 SHEET 10 BA14 ILE B 297 ALA B 299 -1 O ILE B 297 N LEU B 304 SHEET 11 BA14 SER B 533 ASP B 540 1 O GLY B 534 N MET B 298 SHEET 12 BA14 LYS B 326 ILE B 339 -1 O CYS B 327 N ILE B 539 SHEET 13 BA14 LEU B 283 ASN B 284 -1 O ASN B 284 N TYR B 338 SHEET 14 BA14 LYS B 326 ILE B 339 -1 O TYR B 338 N ASN B 284 SHEET 1 BB 9 GLY B 373 PHE B 375 0 SHEET 2 BB 9 LEU B 378 ASP B 388 -1 O LEU B 378 N PHE B 375 SHEET 3 BB 9 THR B 393 VAL B 400 -1 O THR B 393 N ASP B 388 SHEET 4 BB 9 TYR B 487 ILE B 495 -1 O TYR B 487 N VAL B 400 SHEET 5 BB 9 ALA B 424 LEU B 425 -1 O LEU B 425 N HIS B 494 SHEET 6 BB 9 TYR B 487 ILE B 495 -1 O HIS B 494 N LEU B 425 SHEET 7 BB 9 GLU B 456 ASP B 457 0 SHEET 8 BB 9 SER B 432 LYS B 437 -1 O LYS B 437 N GLU B 456 SHEET 9 BB 9 TYR B 487 ILE B 495 -1 O ILE B 488 N TYR B 436 SHEET 1 BC 9 ASN B 463 ASN B 468 0 SHEET 2 BC 9 GLN B 471 GLU B 475 -1 O GLN B 471 N ASN B 468 SHEET 3 BC 9 VAL B 407 LEU B 416 -1 O LEU B 412 N VAL B 474 SHEET 4 BC 9 GLN B 482 ILE B 483 -1 O ILE B 483 N VAL B 407 SHEET 5 BC 9 VAL B 407 LEU B 416 -1 O VAL B 407 N ILE B 483 SHEET 6 BC 9 HIS D 400 ALA D 410 0 SHEET 7 BC 9 TRP B 518 ASN B 530 1 O SER B 520 N HIS D 401 SHEET 8 BC 9 ALA B 504 TYR B 512 -1 O LEU B 505 N ASN B 525 SHEET 9 BC 9 VAL B 407 LEU B 416 -1 O ILE B 408 N TYR B 512 SSBOND 1 CYS A 327 CYS A 541 1555 1555 2.02 SSBOND 2 CYS B 327 CYS B 541 1555 1555 2.05 CRYST1 35.427 61.836 81.777 85.44 81.84 82.45 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028227 -0.003741 -0.003823 0.00000 SCALE2 0.000000 0.016313 -0.001014 0.00000 SCALE3 0.000000 0.000000 0.012377 0.00000